Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries This Pharma Company Is Preparing To Launch Its Lead Candidate By: News Direct July 25, 2024 at 08:58 AM EDT --News Direct--By Johnny Rice, BenzingaLeonard Mazur, CEO and founder of Citius Pharmaceuticals (NASDAQ: CTXR), was recently interviewed by Benzinga.Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in adjunct cancer care, stem cell therapy, and unique prescription products.Mazur spoke about the exciting developments in the company’s assets, including the imminent launch of its first drug on the market.Learn more here:Featured photo by freestocks on Unsplash.Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders.This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.Contact DetailsBenzinga+1 877-440-9464info@benzinga.comCompany Websitehttp://www.benzinga.comView source version on newsdirect.com: https://newsdirect.com/news/this-pharma-company-is-preparing-to-launch-its-lead-candidate-252698575 Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
This Pharma Company Is Preparing To Launch Its Lead Candidate By: News Direct July 25, 2024 at 08:58 AM EDT --News Direct--By Johnny Rice, BenzingaLeonard Mazur, CEO and founder of Citius Pharmaceuticals (NASDAQ: CTXR), was recently interviewed by Benzinga.Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in adjunct cancer care, stem cell therapy, and unique prescription products.Mazur spoke about the exciting developments in the company’s assets, including the imminent launch of its first drug on the market.Learn more here:Featured photo by freestocks on Unsplash.Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders.This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.Contact DetailsBenzinga+1 877-440-9464info@benzinga.comCompany Websitehttp://www.benzinga.comView source version on newsdirect.com: https://newsdirect.com/news/this-pharma-company-is-preparing-to-launch-its-lead-candidate-252698575
--News Direct--By Johnny Rice, BenzingaLeonard Mazur, CEO and founder of Citius Pharmaceuticals (NASDAQ: CTXR), was recently interviewed by Benzinga.Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in adjunct cancer care, stem cell therapy, and unique prescription products.Mazur spoke about the exciting developments in the company’s assets, including the imminent launch of its first drug on the market.Learn more here:Featured photo by freestocks on Unsplash.Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders.This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.Contact DetailsBenzinga+1 877-440-9464info@benzinga.comCompany Websitehttp://www.benzinga.comView source version on newsdirect.com: https://newsdirect.com/news/this-pharma-company-is-preparing-to-launch-its-lead-candidate-252698575